From: Role of multidetector computed tomography in evaluation of resectability of pancreatic cancer
NCCN | |||||||||
---|---|---|---|---|---|---|---|---|---|
Resectable | Borderline resectable | Locally advanced | Metastatic | P value | |||||
Count | % | Count | % | Count | % | Count | % | ||
Arteries a | 0.010 | ||||||||
No contact | 12 | 48% | 3 | 12% | 2 | 8% | 8 | 32% | |
Abutment | 1 | 17% | 2 | 33% | 0 | 0% | 3 | 50% | |
Encasement | 0 | 0% | 0 | 0% | 4 | 36% | 7 | 64% | |
Occlude | 0 | 0% | 0 | 0% | 0 | 0% | 0 | 0% | |
Veinsb | 0.000 | ||||||||
No contact | 5 | 63% | 0 | 0.0% | 0 | 0% | 3 | 37% | |
Abutment | 8 | 62% | 2 | 15% | 0 | 0% | 3 | 23% | |
Encasement | 0 | 0% | 3 | 37% | 1 | 13% | 4 | 50% | |
Occlude | 0 | 0% | 0 | 0% | 5 | 38% | 8 | 62% | |
Lymphatics | 0.006 | ||||||||
No enlarged lymph nodes | 3 | 43% | 3 | 43% | 0 | 0% | 1 | 14% | |
Regional lymph nodes | 10 | 34% | 2 | 7% | 6 | 21% | 11 | 38% | |
Non-regional lymph nodes | 0 | 0% | 0 | 0% | 0 | 0% | 6 | 100% | |
Surgery | 0.000 | ||||||||
No surgery | 1 | 5% | 1 | 5% | 3 | 16% | 14 | 74% | |
P.D | 11 | 79% | 3 | 21% | 0 | 0% | 0 | 0% | |
Exploration | 0 | 0% | 1 | 17% | 1 | 17% | 4 | 66% | |
Bypass | 1 | 33% | 0 | 0.0% | 2 | 67% | 0 | 0.0% |